|
Volumn 101, Issue 4, 2005, Pages
|
Influence of apolipoprotein E genotype on progression of diabetic nephropathy.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
APOLIPOPROTEIN E;
APOLIPOPROTEIN E3;
APOLIPOPROTEIN E4;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DIABETIC NEPHROPATHY;
DISEASE COURSE;
FEMALE;
GENE EXPRESSION REGULATION;
GENE FREQUENCY;
GENETIC POLYMORPHISM;
GENETICS;
GENOTYPE;
HUMAN;
KIDNEY FAILURE;
MALE;
MIDDLE AGED;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
TIME;
AGED;
APOLIPOPROTEIN E3;
APOLIPOPROTEIN E4;
APOLIPOPROTEINS E;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEPHROPATHIES;
DISEASE PROGRESSION;
FEMALE;
GENE EXPRESSION REGULATION;
GENE FREQUENCY;
GENOTYPE;
HUMANS;
KIDNEY FAILURE;
MALE;
MIDDLE AGED;
POLYMORPHISM, GENETIC;
PROSPECTIVE STUDIES;
RANDOMIZED CONTROLLED TRIALS;
TIME FACTORS;
|
EID: 33645804043
PISSN: None
EISSN: 16602129
Source Type: Journal
DOI: 10.1159/000087577 Document Type: Article |
Times cited : (19)
|
References (0)
|